Hernday Natasha (CIK 1780547) reported 3 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-12). Recent activity: Buy JANX (5,500 shares), Buy JANX (3,750 shares), Buy XOMA (5,971 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Janux Therapeutics, Inc. (JANX) | Director | Buy | 5,500 | $0 |
| 2025-06-13 | Janux Therapeutics, Inc. (JANX) | Director | Buy | 3,750 | $0 |
| 2025-05-23 | XOMA Royalty Corp (XOMA) | Director | Buy | 5,971 | $0 |
Source: SEC Form 4 filings · as of 2026-06-12